Evaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items. (Q43099287)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20392860%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Evaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20392860%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

Parkinson's disease dementia

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20392860%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Kolbjørn Brønnick

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20392860%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1

Frederick A Schmitt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20392860%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Xiangyi Meng

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20392860%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Sibel Tekin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20392860%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Jason T Olin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20392860%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

language of work or name

English

0 references

publication date

14 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20392860%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Alzheimer's Disease & Other Dementias

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20392860%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20392860%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20392860%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

407-413

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20392860%20AND%20SRC:MED&resulttype=core&format=json

How common are the "common" neurologic disorders?

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Parkinson's disease: clinical features and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Evaluation of dementia rating scales in Parkinson's disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Rivastigmine for dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Fronto-striatal cognitive deficits at different stages of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Study of verbal working memory in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Cognitive profile of patients with newly diagnosed Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Visuospatial deficits in Parkinson's disease assessed by judgment of line orientation test: error analyses and practice effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Visual dysfunction in Parkinson disease without dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Benefits of rivastigmine on attention in dementia associated with Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Comparison studies of cholinesterase inhibitors for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Executive dyscontrol in dementia, with emphasis on subcortical pathology and the role of butyrylcholinesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patchversus capsule

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

The cognitive drug research computerized assessment system for demented patients: A validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510367486

21 January 2018

Identifiers

DOI

10.1177/1533317510367486

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20392860%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference